Alvotech vs Repligen
ALVO and RGEN side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ALVO and RGEN compare
Alvotech grew revenue faster over the last twelve months (19.7% versus 13.8% for Repligen).
Repligen scores higher on the StockData Score (7 against 3 for Alvotech), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ALVO | RGEN |
|---|---|---|
| Size and price | ||
| Market cap | – | $10.0B |
| Share price | $4.65 | $176.94 |
| Change, 1 year | −41.1% | 19.2% |
| Change, 5 years | −53.0% | −33.7% |
| Beta (5Y) | 0.47 | 1.50 |
| Employees | 1,000 | 2,000 |
| StockData Score | ||
| Total score | 3 | 7 (better) |
| Valuation score | 0 | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 0 | 2 (better) |
| Health score | 1 | 2 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 12.4× |
| P/B | – | 4.8× |
| EV/EBITDA | – | 94.9× |
| P/FCF | – | 93.6× |
| FCF yield | – | 1.1% |
| Fair value | – | $79.82 |
| Margin of safety | – | −122% |
| Growth | ||
| Revenue growth (TTM) | 19.7% (better) | 13.8% |
| Revenue growth, 5Y average | 54.5% (better) | 15.0% |
| Net income growth (TTM) | – | −779% |
| EPS growth, 5Y average | – | −5.0% |
| Profitability | ||
| Gross margin | 59.8% (better) | 53.5% |
| Operating margin | 13.3% (better) | 2.3% |
| Net margin | – | −1.5% |
| FCF margin | −19.6% | 13.2% (better) |
| Return on equity | – | −0.57% |
| Return on invested capital | – | 0.71% |
| Financial health | ||
| Net debt / EBITDA | 10.02 | – |
| Interest coverage | 0.5× | 0.8× (better) |
| Current ratio | 1.65 | 9.88 (better) |
| Altman Z-score | – | 8.14 |
| Piotroski F-score | – | 7 |
| Dividends and buybacks | ||
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | – | 117% |
| Held by insiders | 67.7% | 0.67% |
| Insider net buying, 12 months | – | −$14.2M |
| Superinvestors holding | – | 2 |
| Short interest, % of float | – | 13.5% |
Go deeper
- ALVO stock overview
- ALVO income statement
- ALVO valuation and score
- RGEN stock overview
- RGEN income statement
- RGEN valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.